A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC

PHASE4CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

February 25, 2016

Primary Completion Date

June 10, 2018

Study Completion Date

June 30, 2018

Conditions
Esophageal Neoplasms
Interventions
DRUG

Sodium Glycididazole

Sodium Glycididazole 700mg/m2.Three times a week (once every other one day),before radiation therapy, total 6 weeks.

DRUG

Placebo

Placebo:three times a week (once every other one day),before radiation therapy, total 6 weeks.

Trial Locations (10)

250117

Qianfoshan Hospital of Shandong, Jinan

Qilu Hospital of Shandong University, Jinan

Shandong Cancer Hospital and Institute, Jinan

Jining NO.1 People's Hospital, Jining

Qingdao Center Medical Group, Qingdao

Fei Cheng People's Hospital, Tai’an

An Qiu People's Hospital, Weifang

The Fourth People's Hospitalof Zibo, Zibo

Unknown

Liaocheng People 's Hospital, Liaocheng

Rizhao City People 's Hospital, Rizhao

All Listed Sponsors
lead

Shandong Cancer Hospital and Institute

OTHER

NCT02721563 - A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC | Biotech Hunter | Biotech Hunter